Directory of funded grants

Filter by

720 results found

Designing synthetic extracellular matrices to support neurodegenerative disease modeling

  • Area of research

    Neurodegeneration

  • Disease Area

    Other

  • Competition

    CQDM-Brain Canada Call for Collaborative Research Projects on the Brain

  • Province

    Québec

  • Start Date

    2025

  • Total Grant Amount

    $550,000

  • Health Canada Contribution

    $275,000

Project Overview

We propose to develop chemically defined synthetic extracellular matrices to support neural cells in longterm stable cell culture. Human induced pluripotent stem cells (hiPSCs) have revolutionized disease modeling and drug discovery. Enhanced 2D and 3D culture models have tremendous potential to enable hiPSC development with greater cellular maturity compared to…

In-vivo CAR-T Therapy for Glioblastoma by Novel Non-Viral Gene Editing System

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    CQDM-Brain Canada Call for Collaborative Research Projects on the Brain

  • Province

    Québec

  • Start Date

    2025

  • Total Grant Amount

    $2,015,000

  • Health Canada Contribution

    $1,007,500

Project Overview

Challenge CAR-T therapies have delivered promising results for certain hematological cancers but remain largely ineffective for solid tumours with failure nodes including complex and hostile tumor microenvironments and the lack of adapted technological tools. We propose to adapt a novel gene editing system to develop an in-vivo CAR-T gene editing…

Myelin loss and cognitive impairment following SARS-CoV-2 infection 

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $159,997

  • Health Canada Contribution

    $63,635

Project Overview

Does SARS-CoV-2 infection increase cognitive decline via myelin loss in older individuals? Background: One in 4 persons infected with SARS-CoV-2 (the COVID-19 virus) shows cognitive decline. This decline could be related to white matter damage. The white matter is made of axons connecting neurons with each other. The integrity of…

CODEX Trial

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer’s Association International Grant Program

  • Province

    Ontario

  • Start Date

    2024

  • Total Grant Amount

    $200,000

  • Health Canada Contribution

    $90,910

Project Overview

Each year, over 312 million patients undergo surgery. Anesthesia is a drug-induced reversible, comatose state that facilitates surgery. It is widely assumed cognition returns to baseline afterwards. Surgery and anesthesia induce stress responses in the body, potentially damaging brain cells. Many patients develop postoperative neurocognitive disorders (PND), including delirium (fluctuating…

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): Building a Research, Practice and Policy Foundation

  • Grant Type

    Team grants

  • Area of research

    Mental Health

  • Disease Area

    Mental illness

  • Competition

    2024 CCS Breakthrough Team Grants - Transforming the future of metastatic cancer

  • Province

    Alberta

  • Start Date

    2025

  • Total Grant Amount

    $5,478,935

  • Health Canada Contribution

    $413,500

Project Overview

A new national initiative funded by the Canadian Cancer Society, the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT), is bringing together researchers, clinicians, policymakers, and people living with advanced cancer to explore the potential of psychedelic-assisted therapy as a transformative approach to cancer care. People with advanced cancer often experience…